Established in 2017, Jiangxi Serum Pharma Industries Co., Ltd. has emerged as a titan in the global pharmaceutical and nutritional supply chain. With an annual sales turnover exceeding $10,000,000 USD, we bridge the gap between high-end Chinese manufacturing and the rigorous demands of the global market.
In the modern pharmaceutical landscape, Tea Tree Oil (TTO) is no longer just an "alternative" remedy. It is a potent anti-microbial powerhouse. As a leading supplier, our TTO is characterized by high Terpinen-4-ol (minimum 35-40%) and ultra-low 1,8-Cineole (under 5%), ensuring maximum therapeutic efficacy with minimal skin irritation.
Peppermint oil is a dual-threat agent in both the gastrointestinal pharmaceutical sector and the aromatherapy industry. Our extraction process utilizes steam distillation to preserve the delicate balance of Menthol (approx. 50%) and Menthone, providing the characteristic "cooling" sensation and analgesic effects.
Combining Tea Tree and Peppermint oils creates a synergistic bio-film inhibitor. This combination is currently at the forefront of "Non-Antibiotic" solutions in wound care and personal hygiene, offering a competitive edge to brands looking to bypass traditional chemical biocides.
The global pharmaceutical market is witnessing a 12% CAGR in natural ingredient adoption. Driven by consumer distrust of synthetic additives and the rising threat of antimicrobial resistance (AMR), oils like Tea Tree and Peppermint are being integrated into Tier-1 pharmaceutical products. Our role as a supplier is to ensure these oils meet the same GMP standards as chemical APIs.
Natural oils are subject to climate-driven price swings. Jiangxi Serum Pharma provides Macro-Sourcing Solutions by maintaining strategic reserves and long-term contracts with farms across Australia (for Tea Tree) and the US/India (for Peppermint), shielding our clients from sudden market spikes.
Global enterprises now demand full traceability. Our technical roadmap includes Blockchain-enabled Traceability from the harvest site to the final shipping container, ensuring that every drop of oil is ethically harvested and processed without exploitation.
We offer customized oil-to-powder solutions, allowing hydrophobic oils like Peppermint to be seamlessly integrated into dry tablet or capsule formulations through specialized carrier technology.
Enhancing the stability of volatile oils. Our Co-Crystallization service ensures that the active menthol and terpinen components do not degrade under high-temperature storage conditions.
Monitoring the frontier of synthetic biology to provide bio-identical, fermentation-derived oils for future-proofing your supply chain against traditional agricultural risks.
Navigating the regulatory landscape of the FDA, EMA, and NMPA requires deep expertise. Our team provides comprehensive documentation support, including:
OUR PREMIUM PRODUCTS WILL BRING BACK THE HEALTH
Our pharmaceutical products consist of biological products, vaccines, western medicines, raw material, intermediates, medical consumables, with high quality and affordable prices. We serve as a vital link in the global healthcare chain, ensuring that essential medicines reach those in need with guaranteed potency.
View DetailsQuality is defined by the Terpinen-4-ol content and the absence of contaminants. A pharmaceutical-grade oil must adhere to ISO 4730 standards, ensuring the cineole level is low enough to prevent skin irritation while the therapeutic compounds are maximized.
Yes. We provide Peppermint Oil that is specifically refined for gastrointestinal applications. It meets USP/EP requirements for purity and menthol content, making it ideal for encapsulated medicines targeting IBS and digestive health.
We use nitrogen-blanketed HDPE drums or epoxy-lined aluminum containers to prevent oxidation. Furthermore, we offer technical solutions like micro-encapsulation for clients requiring extended shelf life in challenging climates.
While we handle large-scale enterprise contracts, our MOQ is flexible depending on the product grade. For specialized pharmaceutical intermediates, we can support pilot-scale projects through to mass manufacturing.
Apr 24, 2026
Exploring the shift from shark-based to olive and amaranth-based squalene in global skincare and vaccine adjuvants...
Learn more
Apr 17, 2026
Why this critical molecule remains a cornerstone of modern emergency medicine and inflammation control...
Learn moreApr 08, 2026
The FDA approval of Eli Lilly’s Foundayo marks a new era in metabolic health. Analyzing the impact on the peptide supply chain...
Learn more
